As demonstrated in both figures, variants of SYNE2, ACAN, and PRRT2 genes were more constantly seen in MPN patients with SCs, whereas CEP164 was more commonly altered in control cases. This evidence concerns the gene ACAN and myeloproliferative neoplasm.